Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study.

Eur J Med Res · 2025 · PMC12235812 · PMID 40624547

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp = 0.06so close (0.05 < p ≤ 0.1)

The log-rank test showed a borderline significant difference ( p = 0.06).

also in 11,409 other papers

showed a trendno p-value reported

5 ) showed a trend toward improved hospitalization-free survival in the dapagliflozin group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.